BOTANIX PHARMACEUTICALS LTD
ASX:BOTPharmaceuticals, Biotechnology & Life SciencesToday’s holders own 74.9% of what they think they own, once every option and right converts.
Share count grew 52% in 24 months; runway 2–4 quarters; options/rights overhang 34% of shares
BOTANIX PHARMACEUTICALS LTD’s ordinary share count increased 52.0% between October 2024 and October 2026, its latest share-count filing, to 2.76B shares. The company raised capital twice in the 24-month window for total disclosed proceeds of A$85.0M, most recently a Placement and Security Purchase Plan (SPP) raising A$45.0M in February 2026. Options and rights on issue could convert into 925M new shares, equal to 33.5% of the current share count, none of which are in the money at the current share price; the nearest expiry falls in January 2027. The company has 2 to 4 quarters of funding at the recent spend rate. No proposed securities issues are pending.
Quick answers · 5
When did BOT last raise capital?
The last capital raise in Botanix Pharmaceuticals's filings is Placement and Security Purchase Plan (SPP) of $45.0M announced 17 Feb 2026, one of 2 cash raises in 24 months.
How much placement capacity does BOT have left?
None of the 15% placement capacity counted as used in the last 12 months (estimate). Under ASX Listing Rule 7.1 a company may place up to 15% of its shares in 12 months without shareholder approval.
How much cash does BOT have?
In its quarterly cash report for the quarter ended 30 Sept 2026, Botanix Pharmaceuticals reported $24.4M of cash and estimated 4.2 quarters of funding available at its current rate of spending. That is the company's own estimate.
When do BOT's options expire?
Unexercised options and rights equal 33.5% of Botanix Pharmaceuticals's shares on issue; the nearest expiry is Jan 2027.
How much has BOT's share count grown?
Botanix Pharmaceuticals has 2.76B shares on issue as at 28 Oct 2026, up 52.0% over 24 months according to its Appendix 2A filings.
Shares on issue — last 2 years
Cumulative figures as stated by the company on its daily notice. Latest notice
Cash runway
Issuance timeline
Latest 5 filings (Appendix 2AThe form a company lodges to have new securities quoted on the ASX. It restates how many of each class are on issue. quoted issues, 3G unquoted, 3H cancellations)
| Date | Form | Security | On issue, per this filing | Source |
|---|---|---|---|---|
| 28 Oct 2026 | 2A · quoted issue | BOT : ORDINARY FULLY PAID | 2.76B | Appendix 2A |
| 23 Sept 2026 | 2A · quoted issue | BOT : ORDINARY FULLY PAID | 2.76B | Appendix 2A |
| 31 Aug 2026 | 3H · cancellation | BOT : ORDINARY FULLY PAID | 2.74B | Appendix 3H |
| 14 Aug 2026 | 2A · quoted issue | BOT : ORDINARY FULLY PAID | 2.74B | Appendix 2A |
| 14 Aug 2026 | 3G · unquoted | ORDINARY FULLY PAID | 2.73B | Appendix 3G |
Securities on issue over time
Ordinary shares and every option and rights class, month by month over two years. The top edge is the fully diluted count.
Capital raises
2 cash raises in the last 24 months · 1 in the last 12 months
Forward supply
Every dated event on record that could add securities to the register — option expiries to their stated dates and proposed issues over the next 18 months, on one timeline.
Placement capacity
How much stock a company can place without asking holders. Listing Rule 7.1 / 7.1ARule 7.1 lets a company issue up to 15% of its shares in 12 months without a shareholder vote. Rule 7.1A adds 10% for smaller companies whose holders approve it. allows 15% of ordinary securities in any 12 months, and every Appendix 3BNotice that a company proposes to issue new securities, such as a placement. The securities are not on issue until a later filing confirms it. states how much of it an issue uses.
Pending proposed issues
Options & convertible securities
- Price-triggered842.8M · 30.5% of sharesOptions and warrants — they convert when the share price clears their exercise price.At least 3.0M of it states no exercise price — that much cannot be called in or out of the money.
- Condition-triggered81.8M · 3.0% of sharesPerformance and incentive rights — they convert when a hurdle is met, not at a price, and can lapse to nothing.
Exercise price on record: 839.7M priced, 84.9M where the filing never states one. A security with no exercise price is never counted in the money — nothing is paid to convert it, so there is no price for it to be above.
Each figure is the filing’s own count of securities, not a share count — a 2A never states what one security converts into.
At $0.011 today, 0 securities are in the money (0.0% of shares on issue). No more priced supply until 10× today’s price, which takes it to 773.0M (28.0% of shares).
- Priced supply in the money at the price on the axis — the curve, and the only thing on it. Ten prices, sampled: between two of them the true figure lies between the two.
- 84.9M (9.2% of the supply above) states no exercise price at all. It cannot be called in or out of the money at any price, which is why it is hatched rather than plotted.
- 66.8M more carries an exercise price above ten times today’s — off the right of this axis, and in every total on this page.
| Code | Security | Type | Exercise price | Expiry | On issue | Source |
|---|---|---|---|---|---|---|
| BOTAL | Options | Price-triggered | $0.060 | 31 Jan 2027 | 773.0M | Filing |
| BOTAAJ | Options | Price-triggered | $0.28 | 12 July 2027 | 4.0M | Filing |
| BOTAAI | Options | Price-triggered | $0.36 | 12 July 2027 | 1.0M | Filing |
| BOTAAK | Options | Price-triggered | $0.24 | 12 July 2028 | 10.0M | Filing |
| BOTAJ | Options | Price-triggered | $0.19 | 22 Aug 2028 | 4.0M | Filing |
| BOTAK | Options | Price-triggered | $0.13 | 24 Dec 2029 | 4.3M | Filing |
| BOTAAM | Options | Price-triggered | $0.34 | 8 Jan 2030 | 22.3M | Filing |
| BOTAAN | Options | Price-triggered | $0.47 | 6 Mar 2030 | 3.0M | Filing |
| BOTAG | Options | Price-triggered | $0.41 | 1 Apr 2030 | 5.0M | Filing |
| BOTAAQ | Options | Price-triggered | $0.11 | 8 Oct 2030 | 13.3M | Filing |
| BOTAAP | Warrants | Price-triggered, no exercise price stated | — | — | 3.0M | Filing |
| BOTAAD | Performance rights | Condition-triggered | — | — | 81.8M | Filing Meeting |
“Nil” is a stated nil exercise price: nothing is paid to convert. An em dash means the filing names no exercise price at all. Security is read from the filing’s own class description; an em dash there means the description is not one this table labels. One row is one security class, at the number stated in the most recent quotation application that restated it — linked, and dated, in the last column. For what expires soon across other listed companies, see the options expiry calendar.
A condition-triggered class has no exercise price and usually no expiry: what it vests on is set by a shareholder resolution, not by the register. Where the company lodged a notice of meeting before the class first appears here, it is linked as “Meeting” — that is where terms of this kind are put to shareholders. It is not confirmation that the document sets this class’s conditions, and no link appears where there is no such filing.
- BOTAAOPrice-triggered500k securities → 021 May 2026 Appendix 2A
Director dealings
| Date | Director | Type | Shares | Options | Other | Value | Source |
|---|---|---|---|---|---|---|---|
| 22 Sept 2026 | Vincent Ippolito | Buy incentive | 4.0M | 1.7M | 12.0M | — | 3Y notice |
| 25 Aug 2026 | Dr Patricia Walker | Sell | 1.7M | 1.0M | — | — | 3Y notice |
| 20 Apr 2026 | Daniel Sharp | Other placement | 2.1M | 4.0M | 333k | — | 3Y notice |
| 20 Apr 2026 | Dr Henry William Bosch | Other placement | 20.5M | 1.7M | — | — | 3Y notice |
| 20 Apr 2026 | Dr Patricia Walker | Other placement | 1.7M | — | — | — | 3Y notice |
| 20 Apr 2026 | Stewart Washer | Other placement | 655k | 5.0M | 333k | — | 3Y notice |
| 20 Apr 2026 | Vincent Ippolito | Other placement | 16.7M | 1.7M | — | — | 3Y notice |
Ownership
Latest announcements
Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 Oct 2026.